Efficacy of Intravenous Alfacalcidol in the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis

Publisher： Karger

E-ISSN： 1660-2110|108|2|c141-c147

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.108, Iss.2, 2008-02, pp. : c141-c147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism

By Kurajoh M.   Inaba M.   Okuno S.   Nagayama H.   Yamada S.   Imanishi Y.   Ishimura E.   Shoji S.   Yamakawa T.   Nishizawa Y.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 923-930

Springer Publishing Company

Access to resources Recommend Favorite

Decreases in Parathyroid Gland Volume after Cinacalcet Treatment in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 115, Iss. 3, 2010-04 ,pp. : c195-c202

Karger

Access to resources Recommend Favorite

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 39-50

Karger

Access to resources Recommend Favorite

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite

Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 122, Iss. 1-2, 2013-03 ,pp. : 1-8

Karger

Access to resources Recommend Favorite